SHENZHEN HEPALINK PHARMACEUTICAL GROUP (09989) Reports Unchanged Share Capital in October 2025

Bulletin Express

Nov 03, 2025

SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (stock code: 09989) released a monthly return for October 2025 showing no changes in share capital. The H shares authorized and issued remained at 220,094,500, each with a par value of RMB 1. Meanwhile, A shares (stock code: 002399) listed on the Shenzhen Stock Exchange remained at 1,247,201,704, also with a par value of RMB 1.

At the end of October 2025, total authorized share capital stood at RMB 1,467,296,204, reflecting no adjustments from the previous month. Treasury shares for both H and A stocks were reported as zero, indicating no repurchases or cancellations. The company confirmed that all applicable rules and regulations were followed for this reporting period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1113808569"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1113808569\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1113808569?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-03 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113808569","market":"us","top_or_hot":-1,"title":"SHENZHEN HEPALINK PHARMACEUTICAL GROUP (09989) Reports Unchanged Share Capital in October 2025","media":"Bulletin Express","content":"<p>SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (stock code: 09989) released a monthly return for October 2025 showing no changes in share capital. The H shares authorized and issued remained at 220,094,500, each with a par value of RMB 1. Meanwhile, A shares (stock code: 002399) listed on the Shenzhen Stock Exchange remained at 1,247,201,704, also with a par value of RMB 1.</p>\n<p>At the end of October 2025, total authorized share capital stood at RMB 1,467,296,204, reflecting no adjustments from the previous month. Treasury shares for both H and A stocks were reported as zero, indicating no repurchases or cancellations. The company confirmed that all applicable rules and regulations were followed for this reporting period.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SHENZHEN HEPALINK PHARMACEUTICAL GROUP (09989) Reports Unchanged Share Capital in October 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSHENZHEN HEPALINK PHARMACEUTICAL GROUP (09989) Reports Unchanged Share Capital in October 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-03 22:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (stock code: 09989) released a monthly return for October 2025 showing no changes in share capital. The H shares authorized and issued remained at 220,094,500, each with a par value of RMB 1. Meanwhile, A shares (stock code: 002399) listed on the Shenzhen Stock Exchange remained at 1,247,201,704, also with a par value of RMB 1.</p>\n<p>At the end of October 2025, total authorized share capital stood at RMB 1,467,296,204, reflecting no adjustments from the previous month. Treasury shares for both H and A stocks were reported as zero, indicating no repurchases or cancellations. The company confirmed that all applicable rules and regulations were followed for this reporting period.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09989","symbol_name":"海普瑞","start_time":0,"source_url":"","article_id":"1113808569","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113808569","pubTimestamp":1762180444,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (stock code: 09989) released a monthly return for October 2025 showing no changes in share capital. The H shares authorized and issued remained at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09989":"海普瑞"},"translate_title":"深圳海普瑞药业集团(09989)2025年10月股本不变报告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09989":1},"content_text":"SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. (stock code: 09989) released a monthly return for October 2025 showing no changes in share capital. The H shares authorized and issued remained at 220,094,500, each with a par value of RMB 1. Meanwhile, A shares (stock code: 002399) listed on the Shenzhen Stock Exchange remained at 1,247,201,704, also with a par value of RMB 1.\nAt the end of October 2025, total authorized share capital stood at RMB 1,467,296,204, reflecting no adjustments from the previous month. Treasury shares for both H and A stocks were reported as zero, indicating no repurchases or cancellations. The company confirmed that all applicable rules and regulations were followed for this reporting period.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}